scorecardresearch
Add as a preferred source on Google
Friday, October 24, 2025
TopicIndian pharmaceutical

Topic: Indian pharmaceutical

Chhindwara’s Coldrif deaths show India’s dangerous irony—pharmacy of the world, failing at home

India’s pharmaceutical sector is valued at $50 billion. It has built its reputation on affordability and accessibility. The deaths in Chhindwara tell a different story.

Trump’s 100% pharma tariffs call for Indian firms to reimagine drug exports. Act quickly

If the US is attempting to force localisation, India should respond aggressively with a proactive agenda. Here’s how.

On Camera

US sanctions Rosneft & Lukoil: What we know of 2 oil giants that produce half of Russia’s crude

Rosneft, the Russian state-owned oil behemoth, has large interests in India. Reliance has a contract to purchase 500,000 barrels of crude per day from the firm.

From battle of wits and daring air strikes to artillery fury, new details emerge of Operation Sindoor

Fresh details of operation conducted by IAF, Army have come out in gazette notification giving citations of those who were awarded Vir Chakra for their bravery.

CJI, IPS, IAS & Homebound: A wake-up call 75 years in the making

Education, reservations, govt jobs are meant to bring equality and dignity. That we are a long way from that is evident in the shoe thrown at the CJI and the suicide of Haryana IPS officer. The film Homebound has a lesson too.